375
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review

ORCID Icon, , , , , , & show all
Article: FSO971 | Received 06 Sep 2023, Accepted 30 Jan 2024, Published online: 20 May 2024

References

  • Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J. Hepatol. 56(5), 1181–1188 (2012).
  • Kaplan MM. Primary biliary cirrhosis. N. Engl. J. Med. 335(21), 1570–1580 (1996).
  • Scheuer PJ. Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin. Proc. 73(2), 179–183 (1998).
  • Mago S, Wu GY. Primary sclerosing cholangitis and primary biliary cirrhosis overlap syndrome: a review. J. Clin. Transl. Hepatol. 8(3), 336–346 (2020).
  • Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J. Gastroenterol. 14(21), 3368–3373 (2008).
  • Gregorio GV, Portmann B, Karani J et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33(3), 544–553 (2001).
  • Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28(2), 360–365 (1998).
  • Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28(2), 296–301 (1998).
  • Sundaram S, Kiran S, Mazumdar S, Shukla A. Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis. ACG Case Reports J. 5(1), 54 (1998).
  • Freedman BL, Danford CJ, Patwardhan V, Bonder A. Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis. J. Clin. Med. 9(5), 1449 (2020).
  • Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun. Rev. 13, 441–444 (2014).
  • Sanjeev Sirpaland Natasha Chandok. Primary sclerosing cholangitis: diagnostic and management challenges. Clin. Exp. Gastroenterol. 10, 265–273 (2017).
  • Rubel LR, Seeff LB, Patel V. Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome. Arch. Pathol. Lab. Med. 108(5), 360–361 (1984).
  • Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases. Dig. Dis. Sci. 46(9), 2043–2047 (2001).
  • Kingham JGC, Abbasi A. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective. European J. Gastroenterol. Hepatol. 17(10), 1077–1080 (2005).
  • Jeevagan A. Overlap of primary biliary cirrhosis and primary sclerosing cholangitis – a rare coincidence or a new syndrome. IJGM 3, 143–146 (2010).
  • Floreani A, Motta R, Cazzagon N, Franceschet I, Roncalli M, Del Ross T et al. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Digest. Liver Dis. 47(5), 432–435 (2015).
  • Mandolesi D, Lenzi M, D'Errico A, Festi D, Bazzoli F, Colecchia A. Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: a case report. Gastroenterol. y Hepatolog. 40(10), 669–671 (2017).
  • Del Ross T, Ruffatti A, Floreani A et al. The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report. BMC Musculoskelet. Disord. 17(1), 485 (2016).
  • Benabderrahmane H, Roula D. Overlap syndrome entre cirrhose biliaire primitive et cholangite sclérosante primitive: premier cas dans un contexte d'auto-immunité et d'hypovitaminose D. La Presse Médic. 46(4), 457–459 (2017).
  • Oliveira EMG, Oliveira PM, Becker V, Dellavance A, Andrade LEC, Lanzoni V et al. Overlapping of Primary Biliary Cirrhosis and Small Duct Primary Sclerosing Cholangitis: First Case Report. J. Clin. Med. Res. 4(6), 429–433 (2012).
  • Lewis J. Pathological patterns of biliary disease. Clin. Liver Dis. 10(5), 107–110 (2017).
  • Tanaka A. Current understanding of primary biliary cholangitis. Clin. Mol. Hepatol. 27(1), 1–21 (2021).
  • Paumgartner G. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 36(3), 525–531 (2002).
  • Lindor KD. Ursodiol for primary sclerosing cholangitis. N. Engl. J. Med. 336(10), 691–695 (1997).